Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2017 1
2019 1
2020 4
2021 1
2022 3
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
The Dhaka Call to Action to accelerate the control of cardiovascular diseases in South-East Asia.
Joshi P, Amin MR, Dorin FA, Dzed L, Lethro P, Swarnkar S, Setoya Y, Susanti E, Bhatti L, Mohamed H, Hudha F, Jeyakumaran D, Baral PP, Dorji G, Sridharan S, Qureshi F, Hanbunjerd K, Nieveras OC, da Silva HJN, Pinto L, De Silva A, Kaur J, Gunawardena N, Varghese C. Joshi P, et al. Nat Med. 2024 Jan;30(1):19-20. doi: 10.1038/s41591-023-02678-w. Nat Med. 2024. PMID: 38167936 No abstract available.
Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries.
Kaliki S, Vempuluru VS, Mohamed A, Al-Jadiry MF, Bowman R, Chawla B, Hamid SA, Ji X, Kapelushnik N, Kebudi R, Sthapit PR, Rojanaporn D, Sitorus RS, Yousef YA, Fabian ID; Global Retinoblastoma Study Group. Kaliki S, et al. Ophthalmology. 2024 Apr;131(4):468-477. doi: 10.1016/j.ophtha.2023.10.015. Epub 2023 Oct 13. Ophthalmology. 2024. PMID: 37839559 Free article.
Etiologies and Outcomes of Transaminase Elevation > 1000 IU/L: A Systematic Review and Meta-Analysis.
Mohamed MF, Wadhavkar N, Elfanagely Y, Marino D, Beran A, Abdallah M, Promrat K. Mohamed MF, et al. Dig Dis Sci. 2023 Jul;68(7):2843-2852. doi: 10.1007/s10620-023-07962-w. Epub 2023 May 15. Dig Dis Sci. 2023. PMID: 37184617 Review.
The pooled frequency of ischemic hepatitis was 51% (95% CI 42-60%, I(2) = 91%), viral hepatitis was 13.1% (95% CI 9.7-17.6%, I(2) = 80%), toxins or drug-induced liver injury (DILI) was 13% (95% CI 8-18%, I(2) = 85%), and pancreaticobiliary-related injury was 7.8% (95% CI 4 …
The pooled frequency of ischemic hepatitis was 51% (95% CI 42-60%, I(2) = 91%), viral hepatitis was 13.1% (95% CI 9.7-17.6%, I(2) = 80%), to …
Kratom-induced acute liver injury: A case study and the importance of herbal supplement regulation.
Roma K, Mohammed S, Sieck B, Naik K, Wahid S. Roma K, et al. J Hepatol. 2023 Aug;79(2):581-584. doi: 10.1016/j.jhep.2023.04.026. Epub 2023 Apr 28. J Hepatol. 2023. PMID: 37121435 Free article.
Alternative medicine supplements have become the second most common cause of drug-induced liver injury (DILI) in the US. Kratom is a herbal supplement that is popular for its psychotropic and opioid-like activity. ...
Alternative medicine supplements have become the second most common cause of drug-induced liver injury (DILI) in the US. Kratom is a …
Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature.
Mohamed WT, Jahagirdar V, Fatima I, Ahmed MK, Jaber F, Wang K, Hassan A, Ewing E, Clarkston W, Likhitsup A. Mohamed WT, et al. Cureus. 2023 Feb 17;15(2):e35094. doi: 10.7759/cureus.35094. eCollection 2023 Feb. Cureus. 2023. PMID: 36945289 Free PMC article.
Drug-induced liver injury (DILI) is one of the leading causes of death from acute liver failure (ALF) in the United States, accounting for approximately 13% of ALF cases in the United States. ...At the one-month follow-up, his total bilirubin had fallen from a peak of 530 …
Drug-induced liver injury (DILI) is one of the leading causes of death from acute liver failure (ALF) in the United States, accountin …
Pediatric acute liver failure in Saudi Arabia: prognostic indicators, outcomes and the role of genetic testing.
Alhadab A, AlShihabi H, Mohamed F, AlDuhilib Z, Arain Z, Bader R. Alhadab A, et al. Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):420-430. doi: 10.1097/MEG.0000000000002499. Epub 2022 Dec 23. Eur J Gastroenterol Hepatol. 2023. PMID: 36574286

After indeterminate causes (45.6%), genetic-metabolic diseases and drug-induced liver injury (DILI) were the most common cause with 15.2 and 13%, respectively. ...The death/transplant group had longer intensive care unit stay ( P < 0.001), and on admission they had more

…
After indeterminate causes (45.6%), genetic-metabolic diseases and drug-induced liver injury (DILI) were the most common cause with 1 …
Combination Treatment of Omega-3 Fatty Acids and Vitamin C Exhibited Promising Therapeutic Effect against Oxidative Impairment of the Liver in Methotrexate-Intoxicated Mice.
Alorabi M, Mohammed DS, Mostafa-Hedeab G, El-Sherbeni SA, Negm WA, Mohammed AIA, Al-Kuraishy HM, Nasreldin N, Alotaibi SS, Lawal B, Batiha GE, Conte-Junior CA. Alorabi M, et al. Biomed Res Int. 2022 Apr 20;2022:4122166. doi: 10.1155/2022/4122166. eCollection 2022. Biomed Res Int. 2022. PMID: 35496049 Free PMC article.
Drug-induced liver injury (DILI) is the main cause of liver damage mediated by the excretion of toxic active drug metabolites. ...
Drug-induced liver injury (DILI) is the main cause of liver damage mediated by the excretion of toxic active drug metabolites. ...
Role of liver biopsy in management of liver diseases without hepatic nodules following end of the interferon era: experience of a tertiary referral center.
Ehsan NA, Elsabaawy MM, Sweed DM, Karman EA, Abdelsameea E, Mohamed AA. Ehsan NA, et al. Clin Exp Med. 2023 Feb;23(1):97-105. doi: 10.1007/s10238-022-00797-1. Epub 2022 Mar 9. Clin Exp Med. 2023. PMID: 35262836 Free PMC article.
Etiological diagnosis made by histopathological evaluation was 48 drug-induced liver injury (DILI), 42 nonalcoholic fatty liver disease (NAFLD), 34 chronic hepatitis B, or C with cholestasis, 29 autoimmune hepatitis, 34 primary sclerosing cholangitis, 13 primary biliary ch …
Etiological diagnosis made by histopathological evaluation was 48 drug-induced liver injury (DILI), 42 nonalcoholic fatty liver disea …
The Unmet Needs of Hepatitis E Virus Diagnosis in Suspected Drug-Induced Liver Injury in Limited Resource Setting.
El-Mokhtar MA, Ramadan HK, Thabet MM, Abd-Elkader AS, Fouad M, Sallam MM, Elgohary EA, Abd El-Hafeez AA, Mohamed ME, Sayed IM. El-Mokhtar MA, et al. Front Microbiol. 2021 Oct 8;12:737486. doi: 10.3389/fmicb.2021.737486. eCollection 2021. Front Microbiol. 2021. PMID: 34690979 Free PMC article.
Background: Currently, there are no specific biomarkers for drug-induced liver injury (DILI), and the diagnosis of DILI is based mainly on the exclusion of other causes of liver dysfunction and the recognition of potential causative drugs. ...Conclusion: Hepatitis E …
Background: Currently, there are no specific biomarkers for drug-induced liver injury (DILI), and the diagnosis of DILI is bas …
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
Danjuma MI, Almasri H, Alshokri S, Khir FK, Elmalik A, Battikh NG, Abdallah IMH, Elshafei M, Fatima H, Mohamed MFH, Maghoub Y, Hussain T, Kamal I, Anwer Z, Bidmos MA, Elzouki AN. Danjuma MI, et al. BMC Geriatr. 2020 Sep 14;20(1):346. doi: 10.1186/s12877-020-01732-3. BMC Geriatr. 2020. PMID: 32928134 Free PMC article.
DILI outcomes were adjudicated by the updated Roussel Uclaf Causality Assessment Method (RUCAM). ...Examination of the 38 DILI-drug pairs (n= 38 patients) resulted in a total of 152 ordinal outcome decisions. ...
DILI outcomes were adjudicated by the updated Roussel Uclaf Causality Assessment Method (RUCAM). ...Examination of the 38 DILI …
16 results